Isoko ryo kugabanya ibiro ku isi rikomeje kwiyongera no gutera imbere, hamwe n’ibikenewe byiyongera ku gisubizo cyiza kandi cyiza cyo kugabanya ibiro.Umwe mu bakinnyi bakomeye muri iri soko ni kugabanya ibiro bya semaglutide (CAS 910463-68-2).Semaglutide ni glucagon imeze nka peptide-1 (GLP-1) reseptor agonist ikoreshwa mu kuvura diyabete yo mu bwoko bwa 2 kandi iherutse kwitabwaho ku buryo ishobora gukoreshwa mu gucunga ibiro.
Semaglutide ikora yigana ingaruka za GLP-1, imisemburo isanzwe iba mu mubiri ifasha kugabanya urugero rw'isukari mu maraso.Byerekanwe kugabanya ubushake bwo kurya no gufata ibiryo, biganisha ku kugabanya ibiro kubantu bafite umubyibuho ukabije.Ibi bituma semaglutide ihitamo neza kubashaka kugera ku ntego zabo zo kugabanya ibiro.
Isoko ryo kugabanya ibiro ku isi, harimo na semaglutide, biteganijwe ko hazabaho iterambere rikomeye mu myaka iri imbere.Ibintu nkukwiyongera kw’umubyibuho ukabije, kongera ubumenyi ku ngaruka z’ubuzima ziterwa no kubyibuha birenze urugero, hamwe no gukenera ibisubizo bikabije byo kugabanya ibiro bituma isoko ryaguka.
Ibigo byinshi bikorerwamo ibya farumasi bigira uruhare runini mugutezimbere no gucuruza semaglutide yo gucunga ibiro.Novo Nordisk, umuyobozi ku isi mu kuvura diyabete, yashyizeho inshinge imwe mu cyumweru ya semaglutide yo kugabanya ibiro.Isosiyete yakoze ibizamini byinshi byamavuriro byerekana umutekano ningirakamaro bya semaglutide mugutezimbere ibiro, hamwe nibisubizo bishimishije.
Mu 2021, Ikigo gishinzwe ibiryo n'ibiyobyabwenge muri Amerika (FDA) cyemeje semaglutide yo gucunga ibiro birebire ku bantu bafite umubyibuho ukabije cyangwa ufite ibiro byinshi byibuze byibuze biterwa n'uburemere.Ibi birerekana intambwe yingenzi ku isoko ryo kugabanya ibiro ku isi kuko aribwo bwa mbere GLP-1 yakira reseptor agonist yemerewe cyane cyane gucunga ibiro.
Usibye Amerika, ibindi bihugu byemera ubushobozi bwa semaglutide mu gukemura icyorezo cy'umubyibuho ukabije.Komisiyo y’Uburayi yahaye uburenganzira bwo kwamamaza kuri semaglutide yo kuvura umubyibuho ukabije, hakaba hateganijwe izindi mpapuro ziteganijwe ku masoko mpuzamahanga.Kumenyekana no kwemeza semaglutide yo kugabanya ibiro bikomeza gushimangira umwanya wacyo nkumukinnyi wingenzi ku isoko ryo kugabanya ibiro ku isi.
Mugihe isoko ryisi yose yibintu bigabanya ibiro bikomeje kwaguka, ni ngombwa ko uruganda rukora imiti rushyira imbere iterambere ryibisubizo byizewe kandi bifatika.Semaglutide yerekanye ubushobozi bwo guteza imbere kugabanya ibiro no kuzamura ubuzima bwa metabolike, bigatuma ihagarara neza kugirango ihuze ibyifuzo bikenerwa n’ibicuruzwa bikoresha ibiro.Binyuze mu bushakashatsi bukomeje n’iterambere, semaglutide biteganijwe ko izagira uruhare runini mugukemura icyorezo cy’umubyibuho ukabije ku isi no gufasha abantu kugera ku ntego zabo zo kugabanya ibiro.
Igihe cyo kohereza: Ukuboza-07-2023